Friday, January 27, 2023
HomeMarketAmgen Earnings, Revenue Beat in Q3 By Investing.com

Amgen Earnings, Revenue Beat in Q3 By Investing.com

© Reuters. Amgen Earnings, Revenue Beat in Q3
- Advertisement -

Investing.com – Amgen (NASDAQ:) reported on Thursday third quarter that beat analysts’ forecasts and revenue that topped expectations.

Amgen announced earnings per share of $4.70 on revenue of $6.7B. Analysts polled by Investing.com anticipated EPS of $4.45 on revenue of $6.58B.

Amgen shares are up 18% from the beginning of the year, still down 3.27% from its 52 week high of $274.88 set on November 2.

Amgen shares gained 1.02% in after-hours trade following the report.

Amgen follows other major Healthcare sector earnings this month

Amgen’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.

J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

Story Credit: investing.com

RELATED ARTICLES
- Advertisment -

Most Popular